Target intelligence / Profile preview

Secale cereale pollen allergen proteins (Sec c)

Target
Sec c
Molecular classification
Complex mixture of allergenic proteins, Group 1 allergens, Group 2 allergens, Group 4 allergen (Sec c 4), Group 5 allergen (Sec c 5), Proteins with molecular weights of 28 kDa, Proteins with molecular weights of 33 kDa, Proteins with molecular weights of 48 kDa, Proteins with molecular weights of 67 kDa, Over 30 distinct allergenic proteins, Glycoproteins, Water-soluble components, Lipid-soluble components
01

Overview

Secale cereale (rye) pollen allergens are a complex mixture of protein components that trigger allergic immune responses in sensitized individuals. The pollen contains over 30 distinct allergenic proteins, with major allergens including group 1, 2, 4, and 5 allergen families, characterized by molecular weights of 28, 33, 48, and 67 kDa. These glycoproteins are released rapidly from pollen grains upon hydration, with approximately 40% of total allergenic proteins released within the first 5 minutes of water exposure. Rye pollen represents a significant environmental cause of allergic rhinitis, asthma, and conjunctivitis worldwide, particularly in temperate regions where cultivated rye is grown. The allergens exhibit extensive cross-reactivity with other grass pollen species in the Poaceae family, making molecular component-resolved diagnostics important for accurate patient assessment. Importantly, this entry represents an allergen source rather than a therapeutic drug target, making it unsuitable for inclusion in a therapeutic target database.

Other names
Rye pollen allergensCultivated rye allergensSecale cereale pollen proteinsCommon rye allergens
02

Mechanism of action

Not applicable as a therapeutic target. The allergens function by binding to IgE antibodies on mast cells and basophils, triggering degranulation and allergic inflammatory responses in sensitized individuals.

03

Biological functions

Allergen recognition and immune activation (in sensitized individuals)Plant reproduction (native function)Triggers allergic immune response via IgE binding
04

Disease associations

Allergic rhinitis (hay fever)Asthma (particularly associated with rye pollen allergens)Allergic conjunctivitisPollinosis (pollen allergy)General grass pollen allergies (Poaceae family)
05

Safety considerations

This is an allergen source, not a therapeutic target. The entry is incorrect for a therapeutic target database because Secale cereale pollen allergens are environmental allergens that cause disease rather than drug targets used to treat disease.Clinical manifestations include allergic rhinitis, asthma, and conjunctivitis in sensitized individualsCross-reactivity with other grass pollen allergens (Timothy grass, perennial ryegrass) is extensivePollen is released in huge amounts during pollination season (May-August depending on geography)Sensitization rates vary geographically from 13.54% to 90.0% in different populations
06

Interacting drugs

Cernitin (a rye pollen extract used in immunotherapy)
07

Biomarkers

sIgE (specific immunoglobulin E) levels to individual Sec c allergen componentsSkin prick test reactivity to rye pollen extractComponent-resolved molecular diagnostics showing IgE binding to Sec c 1, Sec c 4, and Sec c 5

Beyond the preview

Go deeper on Secale cereale pollen allergen proteins (Sec c).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secale cereale pollen allergen proteins (Sec c).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call